Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2467 of 6351
-
Experimental cancer combo shows promise but trial halted early
Disease control Stopped earlyThe primary purpose of this study is to assess the safety and tolerability of niraparib or olaparib in combination with RP-3500 (camonsertib), in patients with eligible advanced solid tumors, determine the maximum tolerated dose (MTD) of RP-3500 (camonsertib) in combination with …
Phase 1/2 • Sponsor: Repare Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Nasal spray could replace needles for sickle cell pain emergencies
Symptom relief Stopped earlyThe analgesic treatment for vaso-occlusive crisis (VOC) in sickle-cell patients is an emergency. The reference treatment is morphine, which requires a venous way sometimes difficult to obtain in these patients. Sufentanil intranasal has been shown to be effective in traumatology.…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Experimental Two-Pronged immune therapy tackles tough lymphoma
Disease control CompletedThis is a single-center, open-label study to evaluate the safety and efficacy of C-CAR039 in relapsed and/or refractory B cell Non-Hodgkin's Lymphoma patients.
Phase 1 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug MIJ821 aims to quickly ease depression and suicidal urges
Symptom relief Stopped earlyStudy of efficacy and safety of MIJ821 in addition to comprehensive standard of care on the rapid reduction of symptoms of Major Depressive Disorder (MDD) in subjects who have suicidal ideation with intent
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New stent shows promise in Real-World heart patients
Disease control CompletedDurable polymer was considered to be the cause of a chronic inflammatory response that leadas to impaired endothelialization of the stent strut and subsequently increases the risk of stent thrombosis. Ultimaster stent (Ultimaster, Terumo Corporation, Tokyo, Japan) are thin strut,…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Can less fluid save lives? new septic shock strategy tested
Disease control CompletedBackground: Recent studies have questioned the safety of current fluid resuscitation strategies in patients with septic shock as prospective and observational data suggesting that the resulting fluid overload is associated with mortality. Two strategies have evolved to prevent or…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Stem cells vs. platelets: which boosts knee repair best?
Disease control OngoingThere are no current or past RCT comparing biologic augments for meniscal repair. There is good data supporting both the use of BMVP of the intercondylar notch and intra-articular PRP injections for augmentation of meniscal repair. However, the effectiveness of these augmentation…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Phone app and nurse support may cut heart patient readmissions
Disease control CompletedCoronary artery disease (CAD) is the number one killer of Australians with a high risk for a recurrent event(s) and hospital readmission. Many of these readmissions can be prevented with better management to control the problem of CAD. A disease management program, led by nurses …
Sponsor: Baker Heart and Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
One-Stop shot? study combines flu and COVID boosters for seniors
Prevention CompletedThe main purpose of this Phase II study was to assess the safety and immunogenicity of a dose of Fluzone High-Dose (HD) Quadrivalent vaccine and a third dose or booster dose of Moderna coronavirus disease 19 (COVID-19) vaccine administered concomitantly or singly in adults 65 yea…
Phase 2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 16:36 UTC
-
Mindfulness meets brain zaps: new hope for depression?
Symptom relief OngoingRepetitive Transcranial magnetic stimulation (rTMS) is an FDA-approved treatment for depression that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. The ultimate goal of this treatment is to increase excitability and long-ter…
Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
AI may allow safer breast MRIs with lower contrast doses
Diagnosis CompletedThe purpose of this study is to evaluate the ability of AI to correctly aid in characterization of benign and malignant lesions even when a low dose of gadolinium is administered. This study is relevant for several reasons, most notably being the reduction of MRI dose and decreas…
Phase 1 • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Can disposable surgical tools make hip replacement cheaper and safer?
Disease control CompletedThe main objective of the study is to compare the use of single-use ancillary reaming material during total hip replacement and conventional reusable ancillary reaming material. The assessment will focus on the medico-economic differences found in this prospective randomized stu…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New spine device aims to fix crooked necks
Disease control OngoingMulti-center, prospective, non-randomized study to evaluate Symphony™ Posterior Cervical System in the setting of surgical treatment of adult cervical deformity.
Sponsor: International Spine Study Group Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a quick scope procedure help women get pregnant faster after miscarriage?
Disease control Recruiting nowRationale: Elective immediate dilation and curettage (D\&C) for miscarriage is associated with the occurrence of intrauterine adhesions (IUA). IUAs may be associated with subsequent subfertility and premature birth. Recent studies have shown that in women with miscarriage, medica…
Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a video call save lives? telehealth tested in ERs for suicide prevention
Knowledge-focused CompletedThe study will rigorously evaluate whether synchronous, within-visit telemental health evaluation and intervention services can successfully overcome poor access to behavioral health and substandard suicide-related care in emergency departments (EDs), including evaluating the imp…
Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Smartwatches may predict recovery after surgery or cancer treatment
Knowledge-focused Recruiting nowThe overarching goal of this research is to use machine learning analysis of high-resolution data-collected by wearable technology-to predict complications and poor recovery in patients undergoing treatment for benign or malignant conditions.
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
Disease control CompletedRivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE (RISAPS): a randomised, controlled, open-label, phase IIb, non-inferiority proof of principle trial. 40 patients will be randomised with a ratio of 1:1 to receive either: * Rivar…
Phase 2 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New spinal implant aims to ease back pain from worn discs
Disease control Recruiting nowThe goal of this observational study is to confirm the safety and efficacy of the Hexanium TLIF system in the treatment of skeletally mature patients suffering from degenerative disc disease (disease that occurs when the spinal disk break down). Part of their standard of care, p…
Sponsor: SPINEVISION SAS • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Massive study aims to improve liver transplant decisions
Knowledge-focused Recruiting nowManagement of ACLF is mainly supportive. The poor outcomes lead physicians to consider liver transplantation as an option, even if controversial. In sicker recipients, LT results in immediate survival, but poor medium-term survival rates in some studies. The scarcity of deceased …
Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Heart surgery lung risk: which ventilation method wins?
Disease control CompletedControversies remain concerning the best intraoperative mechanical ventilation regimen for major cardiac surgery. While the use of intra operative low tidal volumes is now standard practice, the optimal level of positive end-expiratory pressure (PEEP) and the use of recruitment m…
Sponsor: Rennes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC